Oh, Soo-Jin http://orcid.org/0000-0001-9267-2039
Hwang, Yeseong http://orcid.org/0000-0002-1739-4443
Hur, Kyu Yeon
Lee, Myung-Shik http://orcid.org/0000-0003-3292-1720
Funding for this research was provided by:
National Research Foundation of Korea (NRF-2019R1A2C3002924, 2017M3A9G7073521)
Korea Drug Development Fund (HN22C0278)
Soonchunhyang University (20220346)
Article History
Received: 4 September 2022
Revised: 22 February 2023
Accepted: 23 February 2023
First Online: 21 March 2023
Competing interests
: M-SL in the CEO of LysoTech, Inc. The authors declare no competing interests.